Lung Cancer Genomic Testing Market Size, Share, Trends, Growth 2034
Lung Cancer Genomic Testing Market By Sample Type (Liquid Biopsy and Tissue Biopsy), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Fluorescence in Situ Hybridization), By Type (Services and Products), By End-User (Hospitals/Clinics, Research Organization, and Diagnostic Laboratories), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 209 Report Code: ZMR-7133
Published Date: Sep-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.65 Billion | USD 4.05 Billion | 9.37% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Lung Cancer Genomic Testing Market, (2023 - 2030) (USD Billion)
- 2.2 Global Lung Cancer Genomic Testing Market : snapshot
- Chapter 3. Global Lung Cancer Genomic Testing Market - Industry Analysis
- 3.1 Lung Cancer Genomic Testing Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing cases of lung cancer to act as a major growth propeller
- 3.3 Market Restraints
- 3.3.1. High cost to restrict market expansion
- 3.4 Market Opportunities
- 3.4.1. Growth in targeted therapy options to provide multiple expansion opportunities
- 3.5 Market Challenges
- 3.5.1. Heterogeneous and complex tumors to challenge market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Sample Type
- 3.7.2 Market attractiveness analysis By Technology
- 3.7.3 Market attractiveness analysis By Type
- 3.7.4 Market attractiveness analysis By End-User
- Chapter 4. Global Lung Cancer Genomic Testing Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Lung Cancer Genomic Testing Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Lung Cancer Genomic Testing Market - Sample Type Analysis
- 5.1 Global Lung Cancer Genomic Testing Market overview: By Sample Type
- 5.1.1 Global Lung Cancer Genomic Testing Market share, By Sample Type, 2022 and 2030
- 5.2 Liquid Biopsy
- 5.2.1 Global Lung Cancer Genomic Testing Market by Liquid Biopsy, 2023 - 2030 (USD Billion)
- 5.3 Tissue Biopsy
- 5.3.1 Global Lung Cancer Genomic Testing Market by Tissue Biopsy, 2023 - 2030 (USD Billion)
- 5.1 Global Lung Cancer Genomic Testing Market overview: By Sample Type
- Chapter 6. Global Lung Cancer Genomic Testing Market - Technology Analysis
- 6.1 Global Lung Cancer Genomic Testing Market overview: By Technology
- 6.1.1 Global Lung Cancer Genomic Testing Market share, By Technology, 2022 and 2030
- 6.2 Next-Generation Sequencing (NGS)
- 6.2.1 Global Lung Cancer Genomic Testing Market by Next-Generation Sequencing (NGS), 2023 - 2030 (USD Billion)
- 6.3 Polymerase Chain Reaction (PCR)
- 6.3.1 Global Lung Cancer Genomic Testing Market by Polymerase Chain Reaction (PCR), 2023 - 2030 (USD Billion)
- 6.4 Fluorescence in Situ Hybridization
- 6.4.1 Global Lung Cancer Genomic Testing Market by Fluorescence in Situ Hybridization, 2023 - 2030 (USD Billion)
- 6.1 Global Lung Cancer Genomic Testing Market overview: By Technology
- Chapter 7. Global Lung Cancer Genomic Testing Market - Type Analysis
- 7.1 Global Lung Cancer Genomic Testing Market overview: By Type
- 7.1.1 Global Lung Cancer Genomic Testing Market share, By Type, 2022 and 2030
- 7.2 Services
- 7.2.1 Global Lung Cancer Genomic Testing Market by Services, 2023 - 2030 (USD Billion)
- 7.3 Products
- 7.3.1 Global Lung Cancer Genomic Testing Market by Products, 2023 - 2030 (USD Billion)
- 7.1 Global Lung Cancer Genomic Testing Market overview: By Type
- Chapter 8. Global Lung Cancer Genomic Testing Market - End-User Analysis
- 8.1 Global Lung Cancer Genomic Testing Market overview: By End-User
- 8.1.1 Global Lung Cancer Genomic Testing Market share, By End-User, 2022 and 2030
- 8.2 Hospitals/Clinics
- 8.2.1 Global Lung Cancer Genomic Testing Market by Hospitals/Clinics, 2023 - 2030 (USD Billion)
- 8.3 Research Organization
- 8.3.1 Global Lung Cancer Genomic Testing Market by Research Organization, 2023 - 2030 (USD Billion)
- 8.4 Diagnostic Laboratories
- 8.4.1 Global Lung Cancer Genomic Testing Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
- 8.1 Global Lung Cancer Genomic Testing Market overview: By End-User
- Chapter 9. Lung Cancer Genomic Testing Market - Regional Analysis
- 9.1 Global Lung Cancer Genomic Testing Market Regional Overview
- 9.2 Global Lung Cancer Genomic Testing Market Share, by Region, 2022 & 2030 (USD Billion)
- 9.3. North America
- 9.3.1 North America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.3.1.1 North America Lung Cancer Genomic Testing Market, by Country, 2023 - 2030 (USD Billion)
- 9.3.1 North America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4 North America Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030
- 9.4.1 North America Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030 (USD Billion)
- 9.5 North America Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030
- 9.5.1 North America Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030 (USD Billion)
- 9.6 North America Lung Cancer Genomic Testing Market, by Type, 2023 - 2030
- 9.6.1 North America Lung Cancer Genomic Testing Market, by Type, 2023 - 2030 (USD Billion)
- 9.7 North America Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030
- 9.7.1 North America Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4.2.1 Europe Lung Cancer Genomic Testing Market, by Country, 2023 - 2030 (USD Billion)
- 9.4.2 Europe Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4 Europe Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030
- 9.4.1 Europe Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030 (USD Billion)
- 9.5 Europe Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030
- 9.5.1 Europe Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030 (USD Billion)
- 9.6 Europe Lung Cancer Genomic Testing Market, by Type, 2023 - 2030
- 9.6.1 Europe Lung Cancer Genomic Testing Market, by Type, 2023 - 2030 (USD Billion)
- 9.7 Europe Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030
- 9.7.1 Europe Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.5.3.1 Asia Pacific Lung Cancer Genomic Testing Market, by Country, 2023 - 2030 (USD Billion)
- 9.5.3 Asia Pacific Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4 Asia Pacific Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030
- 9.4.1 Asia Pacific Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030 (USD Billion)
- 9.5 Asia Pacific Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030
- 9.5.1 Asia Pacific Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030 (USD Billion)
- 9.6 Asia Pacific Lung Cancer Genomic Testing Market, by Type, 2023 - 2030
- 9.6.1 Asia Pacific Lung Cancer Genomic Testing Market, by Type, 2023 - 2030 (USD Billion)
- 9.7 Asia Pacific Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030
- 9.7.1 Asia Pacific Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.6.4.1 Latin America Lung Cancer Genomic Testing Market, by Country, 2023 - 2030 (USD Billion)
- 9.6.4 Latin America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4 Latin America Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030
- 9.4.1 Latin America Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030 (USD Billion)
- 9.5 Latin America Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030
- 9.5.1 Latin America Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030 (USD Billion)
- 9.6 Latin America Lung Cancer Genomic Testing Market, by Type, 2023 - 2030
- 9.6.1 Latin America Lung Cancer Genomic Testing Market, by Type, 2023 - 2030 (USD Billion)
- 9.7 Latin America Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030
- 9.7.1 Latin America Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Country, 2023 - 2030 (USD Billion)
- 9.7.5 The Middle-East and Africa Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 9.4 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030
- 9.4.1 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Sample Type, 2023 - 2030 (USD Billion)
- 9.5 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030
- 9.5.1 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Technology, 2023 - 2030 (USD Billion)
- 9.6 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Type, 2023 - 2030
- 9.6.1 The Middle-East and Africa Lung Cancer Genomic Testing Market, by Type, 2023 - 2030 (USD Billion)
- 9.7 The Middle-East and Africa Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030
- 9.7.1 The Middle-East and Africa Lung Cancer Genomic Testing Market, by End-User, 2023 - 2030 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 CD Genomics
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Qiagen NV
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Laboratory Corporation of America Holdings
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 NeoGenomics Laboratories
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Agilent Technologies Inc.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Illumina Inc.
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Thermo Fischer Scientific Inc.
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Abbott Laboratories Inc.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Quest Diagnostics Inc.
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 OncoDNA
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Centogene N.V.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Admera Health
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 CeGaT GmbH
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 OPKO Health Inc.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 F. Hoffmann-La Roche AG.
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.1 CD Genomics
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Lung Cancer Genomic Testing Market attractiveness, By Sample Type
- 6. Global Lung Cancer Genomic Testing Market attractiveness, By Technology
- 7. Global Lung Cancer Genomic Testing Market attractiveness, By Type
- 8. Global Lung Cancer Genomic Testing Market attractiveness, By End-User
- 9. Global Lung Cancer Genomic Testing Market share by Sample Type, 2023 and 2030 (USD Billion)
- 10. Global Lung Cancer Genomic Testing Market by Liquid Biopsy, 2023 - 2030 (USD Billion)
- 11. Global Lung Cancer Genomic Testing Market by Tissue Biopsy, 2023 - 2030 (USD Billion)
- 12. Global Lung Cancer Genomic Testing Market share by Technology, 2023 and 2030 (USD Billion)
- 13. Global Lung Cancer Genomic Testing Market by Next-Generation Sequencing (NGS), 2023 - 2030 (USD Billion)
- 14. Global Lung Cancer Genomic Testing Market by Polymerase Chain Reaction (PCR), 2023 - 2030 (USD Billion)
- 15. Global Lung Cancer Genomic Testing Market by Fluorescence in Situ Hybridization, 2023 - 2030 (USD Billion)
- 16. Global Lung Cancer Genomic Testing Market share by Type, 2023 and 2030 (USD Billion)
- 17. Global Lung Cancer Genomic Testing Market by Services, 2023 - 2030 (USD Billion)
- 18. Global Lung Cancer Genomic Testing Market by Products, 2023 - 2030 (USD Billion)
- 19. Global Lung Cancer Genomic Testing Market share by End-User, 2023 and 2030 (USD Billion)
- 20. Global Lung Cancer Genomic Testing Market by Hospitals/Clinics, 2023 - 2030 (USD Billion)
- 21. Global Lung Cancer Genomic Testing Market by Research Organization, 2023 - 2030 (USD Billion)
- 22. Global Lung Cancer Genomic Testing Market by Diagnostic Laboratories, 2023 - 2030 (USD Billion)
- 23. Global Lung Cancer Genomic Testing Market share, by Region, 2023 and 2030
- 24. North America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 25. Europe Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 26. Asia Pacific Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 27. Latin America Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
- 28. The Middle-East and Africa Lung Cancer Genomic Testing Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Lung Cancer Genomic Testing Market: Snapshot
- 2. Drivers of the Lung Cancer Genomic Testing Market: impact analysis
- 3. North America Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 4. North America Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 5. North America Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 6. North America Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 7. U.S. Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 8. U.S. Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 9. U.S. Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 10. U.S. Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 11. Canada Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 12. Canada Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 13. Canada Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 14. Canada Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 15. Europe Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 16. Europe Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 17. Europe Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 18. Europe Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 19. Germany Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 20. Germany Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 21. Germany Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 22. Germany Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 23. France Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 24. France Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 25. France Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 26. France Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 27. U.K. Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 28. U.K. Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 29. U.K. Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 30. U.K. Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 31. Italy Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 32. Italy Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 33. Italy Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 34. Italy Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 35. Spain Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 36. Spain Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 37. Spain Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 38. Spain Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 39. Rest of Europe Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 40. Rest of Europe Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 41. Rest of Europe Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 42. Rest of Europe Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 43. Asia Pacific Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 44. Asia Pacific Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 45. Asia Pacific Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 46. Asia Pacific Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 47. China Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 48. China Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 49. China Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 50. China Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 51. Japan Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 52. Japan Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 53. Japan Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 54. Japan Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 55. India Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 56. India Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 57. India Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 58. India Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 59. South Korea Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 60. South Korea Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 61. South Korea Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 62. South Korea Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 63. South-East Asia Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 64. South-East Asia Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 65. South-East Asia Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 66. South-East Asia Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 67. Rest of Asia Pacific Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 68. Rest of Asia Pacific Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 69. Rest of Asia Pacific Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 70. Rest of Asia Pacific Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 71. Latin America Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 72. Latin America Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 73. Latin America Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 74. Latin America Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 75. Brazil Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 76. Brazil Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 77. Brazil Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 78. Brazil Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 79. Mexico Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 80. Mexico Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 81. Mexico Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 82. Mexico Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 83. Rest of Latin America Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 84. Rest of Latin America Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 85. Rest of Latin America Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 86. Rest of Latin America Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 87. The Middle-East and Africa Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 88. The Middle-East and Africa Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 89. The Middle-East and Africa Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 90. The Middle-East and Africa Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 91. GCC Countries Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 92. GCC Countries Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 93. GCC Countries Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 94. GCC Countries Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 95. South Africa Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 96. South Africa Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 97. South Africa Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 98. South Africa Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
- 99. Rest of Middle-East Africa Lung Cancer Genomic Testing Market revenue, By Sample Type, 2023 - 2030 (USD Billion)
- 100. Rest of Middle-East Africa Lung Cancer Genomic Testing Market revenue, By Technology, 2023 - 2030 (USD Billion)
- 101. Rest of Middle-East Africa Lung Cancer Genomic Testing Market revenue, By Type, 2023 - 2030 (USD Billion)
- 102. Rest of Middle-East Africa Lung Cancer Genomic Testing Market revenue, By End-User, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
The global industry stands on the analysis of the cancer cell Deoxyribonucleic acid (DNA) that further helps to identify various associated mutations that cause cell growth.
The global lung cancer genomic testing market is projected to grow owing to the increasing cases of lung cancer across the world. The number one cause of lung cancer is smoking while other factors also contribute to the rising number of patients.
According to a study, the global lung cancer genomic testing market size was worth around USD 1.65 Billion in 2024 and is expected to reach USD 4.05 Billion by 2034.
The global lung cancer genomic testing market is expected to grow at a CAGR of 9.37% during the forecast period.
The global lung cancer genomic testing market is projected to witness the highest growth in North America with the US leading the regional growth.
The global lung cancer genomic testing market is led by players like CD Genomics, Qiagen NV, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Agilent Technologies, Inc., Illumina, Inc., Thermo Fischer Scientific, Inc., Abbott Laboratories, Inc., Quest Diagnostics, Inc., OncoDNA, Centogene N.V., Admera Health, CeGaT GmbH, OPKO Health, Inc., and F. Hoffmann-La Roche AG.
The report explores crucial aspects of the lung cancer genomic testing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
